Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

Spinoff of women’s health/off-patent brands/biosimilars into new (as

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 748
Posts 115,220
Boards Moderated 14
Alias Born 09/05/02
160x600 placeholder
Merck announces positive mid-stage trial data for COVID-19 antiviral drug Seeking Alpha - 3/6/2021 9:07:57 PM
U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines--3rd Update Dow Jones News - 3/6/2021 5:18:00 PM
U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines--2nd Update Dow Jones News - 3/6/2021 5:00:00 PM
U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines--Update Dow Jones News - 3/6/2021 4:47:00 PM
Covid-19 Pill Shows Promise in Preliminary Testing Dow Jones News - 3/6/2021 12:30:00 AM
Ridgeback Biotherapeutics & Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic... Business Wire - 3/6/2021 12:01:00 AM
Merck Begins Tender Offer to Acquire Pandion Therapeutics Business Wire - 3/4/2021 6:45:00 AM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 6th Update Dow Jones News - 3/3/2021 7:47:00 AM
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 Business Wire - 3/3/2021 6:45:00 AM
Merck to Present at the Barclays Global Healthcare Conference Business Wire - 3/3/2021 6:45:00 AM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 6th Update Dow Jones News - 3/2/2021 10:14:00 PM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 5th Update Dow Jones News - 3/2/2021 6:56:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--3rd Update Dow Jones News - 3/2/2021 5:55:00 PM
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufac... Business Wire - 3/2/2021 4:30:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--3rd Update Dow Jones News - 3/2/2021 2:22:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--2nd Update Dow Jones News - 3/2/2021 12:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:58:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:56:48 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:50:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:48:40 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:44:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:42:02 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:36:35 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:14:45 AM
Merck to Help J&J Make Its Covid-19 Vaccine, Biden to Announce--Update Dow Jones News - 3/2/2021 9:54:00 AM
DewDiligence Member Level  Wednesday, 02/05/20 08:20:57 AM
Re: None
Post # of 586 
Spinoff of women’s health/off-patent brands/biosimilars into new (as yet unnamed) company is planned for 1H21:

https://finance.yahoo.com/news/merck-focus-key-growth-pillars-114500519.html

The spinoff is expected to have ~$6.5B of annual sales (~15% of existing MRK), of which 75% will be ex-US.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences